Sun Pharma.Inds.

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,702.10",
    "chg": 74.2,
    "chgp": "4.56%",
    "dir": 1,
    "prev_price": "1,627.90",
    "mcapval": "405,272.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE044A01036",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "87.92 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Sun Pharmaceutical Industries Ltd Opens Strong with Significant Gap Up on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-opens-strong-with-significant-gap-up-on-3-feb-2026-3818139",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaceutic_gapup_3818139.png",
        "date": "2026-02-03 10:03:40",
        "description": "Sun Pharmaceutical Industries Ltd commenced trading on 3 Feb 2026 with a significant gap up, opening 5.41% higher than its previous close, signalling robust positive sentiment in the Pharmaceuticals & Biotechnology sector. This strong start was accompanied by sustained momentum throughout the day, with the stock outperforming both its sector and the broader market indices."
      },
      {
        "title": "Sun Pharmaceutical Sees Surge in Call Option Activity Amid Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-surge-in-call-option-activity-amid-bullish-momentum-3818084",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaceutic_most_active_stocks_calls_3818084.png",
        "date": "2026-02-03 10:01:14",
        "description": "Sun Pharmaceutical Industries Ltd (SUNPHARMA) has witnessed a notable surge in call option trading, signalling increased bullish sentiment among investors. The pharmaceutical giant’s stock has outperformed its sector peers, supported by strong price action and significant open interest in near-term call options, particularly at the ₹1700 strike price expiring on 24 February 2026."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Hits Intraday High with Strong 3.42% Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-intraday-high-with-strong-342-surge-3817758",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaceutic_priceRelatedfactors_3817758.png",
        "date": "2026-02-03 09:44:37",
        "description": "Sun Pharmaceutical Industries Ltd demonstrated robust intraday performance on 3 Feb 2026, surging to an intraday high of Rs 1,725, marking a 5.9% rise from the previous close. The stock outpaced the broader Pharmaceuticals & Biotechnology sector and the Sensex, reflecting strong trading momentum amid a mixed market backdrop."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-and-market-dynamics-3817454",
        "imagepath": "",
        "date": "2026-02-03 09:24:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index is a hallmark of market leadership and liquidity. Sun Pharmaceutical Industries Ltd’s inclusion reflects its substantial market capitalisation, robust trading volumes, and sectoral prominence. With a market cap of ₹4,04,179.97 crores, it ranks among the largest pharmaceutical companies in India, reinforcing its role as a bellwether for the sector.</p>\n                <p>Index membership not only enhances visibility among domestic and global investors but also ensures automatic inclusion in numerous passive funds and ETFs tracking the Nifty 50. This institutional interest often translates into greater stability and liquidity, although it can also amplify volatility during index ..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-technical-momentum-shifts-amid-mixed-market-signals-3815518",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaceutic_technicaldot_3815518.png",
        "date": "2026-02-02 08:04:50",
        "description": "Sun Pharmaceutical Industries Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a modest day gain of 0.95%, the stock’s broader technical signals suggest a cautious outlook amid mixed momentum cues."
      },
      {
        "title": "Has Sun Pharmaceutical Industries Ltd declared dividend?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/has-sun-pharmaceutical-industries-ltd-declared-dividend-3815073",
        "imagepath": "",
        "date": "2026-02-01 23:30:57",
        "description": "Sun Pharmaceutical Industries Ltd has declared a dividend.\n\nDividend Details:\n- Percentage announced: 1100%\n- Amount per share: 5.5\n- Ex-date: 05 Feb 26\n\nDividend Yield: 1%\n\nTotal Returns by Period:\nIn the 3-month period, the price return was -5.48%, the dividend return was 0.65%, resulting in a total return of -4.83%.\n\nIn the 6-month period, the price return was -7.19%, the dividend return was 0.67%, leading to a total return of -6.52%.\n\nFor the 1-year period, the price return was -7.74%, the dividend return was 0.95%, culminating in a total return of -6.79%.\n\nOver the 2-year period, the price return was 17.4%, the dividend return was 2.09%, resulting in a total return of 19.49%.\n\nIn the 3-year period, the price return was 53.22%, the dividend return was 4.52%, leading to a total return of 57.74%.\n\nFor the 4-year period, the price return was 94.64%, the dividend return was 6.50%, culminating in a total ret..."
      },
      {
        "title": "Sun Pharmaceutical Sees Heavy Put Option Activity Amid Bearish Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-heavy-put-option-activity-amid-bearish-sentiment-3814408",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaceutic_most_active_stocks_puts_3814408.png",
        "date": "2026-02-01 11:00:13",
        "description": "Sun Pharmaceutical Industries Ltd has emerged as the most active stock in put options trading, signalling a notable shift in market sentiment. With significant volumes concentrated at the ₹1600 strike price for the 24 February 2026 expiry, investors appear to be positioning for downside risk or hedging against potential volatility in the pharmaceutical giant’s shares."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd: Navigating Nifty 50 Membership Amid Mixed Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-amid-mixed-performance-3813881",
        "imagepath": "",
        "date": "2026-02-01 09:21:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index confers considerable advantages to Sun Pharmaceutical Industries Ltd, including enhanced visibility among domestic and international investors, increased liquidity, and inclusion in numerous passive investment funds and ETFs. This status often acts as a stabilising factor during volatile market phases, as index funds are mandated to maintain holdings in constituent stocks. However, it also subjects the company to heightened scrutiny and performance expectations relative to peers.</p>\n                <p>Sun Pharma’s current market capitalisation stands at a robust ₹3,82,694 crores, categorising it firmly as a large-cap stock. This scale underpins its eligibility for index inclus..."
      },
      {
        "title": "Are Sun Pharmaceutical Industries Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sun-pharmaceutical-industries-ltd-latest-results-good-or-bad-3813375",
        "imagepath": "",
        "date": "2026-01-31 19:27:59",
        "description": "Sun Pharmaceutical Industries Ltd's latest financial results for the quarter ending December 2025 highlight a strong operational performance, showcasing the company's ability to maintain momentum across key metrics. The net sales reached ₹15,520.54 crores, reflecting a sequential growth of 7.20% from the previous quarter and a year-on-year increase of 13.49%. This marks the highest quarterly revenue in the company's history, driven by robust demand in both domestic and international markets.\n\nThe net profit for the same quarter stood at ₹3,368.81 crores, which is an 8.05% increase compared to the previous quarter and a notable 16.03% rise year-on-year. The operating margin for the quarter was reported at 31.99%, showing a sequential improvement of 56 basis points from the prior quarter, indicating enhanced operational efficiency and effective cost management.\n\nAdditionally, the company's average return on e..."
      }
    ],
    "total": 969,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding Intimation under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
      "source": "NSE",
      "caption": "Sun Pharmaceutical Industries Limited - Other General Purpose",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 06, 2019, titled \"Sun Pharma and AstraZeneca enter into License Agreement for Novel Oncology products in China\".",
      "source": "NSE",
      "caption": "Sun Pharmaceutical Industries Limited - Press Release",
      "datetime": "06-Nov-2019"
    },
    {
      "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Please find enclosed Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018'.",
      "source": "NSE",
      "caption": "Sun Pharmaceutical Industries Limited - Updates",
      "datetime": "18-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>1100%</strong> dividend, ex-date: 05 Feb 26",
          "dt": "2026-02-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sun Pharmaceutical Industries Ltd Opens Strong with Significant Gap Up on 3 Feb 2026

2026-02-03 10:03:40

Sun Pharmaceutical Industries Ltd commenced trading on 3 Feb 2026 with a significant gap up, opening 5.41% higher than its previous close, signalling robust positive sentiment in the Pharmaceuticals & Biotechnology sector. This strong start was accompanied by sustained momentum throughout the day, with the stock outperforming both its sector and the broader market indices.

Read full news article

Sun Pharmaceutical Sees Surge in Call Option Activity Amid Bullish Momentum

2026-02-03 10:01:14

Sun Pharmaceutical Industries Ltd (SUNPHARMA) has witnessed a notable surge in call option trading, signalling increased bullish sentiment among investors. The pharmaceutical giant’s stock has outperformed its sector peers, supported by strong price action and significant open interest in near-term call options, particularly at the ₹1700 strike price expiring on 24 February 2026.

Read full news article

Sun Pharmaceutical Industries Ltd Hits Intraday High with Strong 3.42% Surge

2026-02-03 09:44:37

Sun Pharmaceutical Industries Ltd demonstrated robust intraday performance on 3 Feb 2026, surging to an intraday high of Rs 1,725, marking a 5.9% rise from the previous close. The stock outpaced the broader Pharmaceuticals & Biotechnology sector and the Sensex, reflecting strong trading momentum amid a mixed market backdrop.

Read full news article

Sun Pharmaceutical Industries Ltd: Navigating Nifty 50 Membership and Market Dynamics

2026-02-03 09:24:12

Significance of Nifty 50 Membership

Being part of the Nifty 50 index is a hallmark of market leadership and liquidity. Sun Pharmaceutical Industries Ltd’s inclusion reflects its substantial market capitalisation, robust trading volumes, and sectoral prominence. With a market cap of ₹4,04,179.97 crores, it ranks among the largest pharmaceutical companies in India, reinforcing its role as a bellwether for the sector.

Index membership not only enhances visibility among domestic and global investors but also ensures automatic inclusion in numerous passive funds and ETFs tracking the Nifty 50. This institutional interest often translates into greater stability and liquidity, although it can also amplify volatility during index ...

Read full news article

Sun Pharmaceutical Industries Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-02 08:04:50

Sun Pharmaceutical Industries Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a modest day gain of 0.95%, the stock’s broader technical signals suggest a cautious outlook amid mixed momentum cues.

Read full news article

Has Sun Pharmaceutical Industries Ltd declared dividend?

2026-02-01 23:30:57

Sun Pharmaceutical Industries Ltd has declared a dividend. Dividend Details: - Percentage announced: 1100% - Amount per share: 5.5 - Ex-date: 05 Feb 26 Dividend Yield: 1% Total Returns by Period: In the 3-month period, the price return was -5.48%, the dividend return was 0.65%, resulting in a total return of -4.83%. In the 6-month period, the price return was -7.19%, the dividend return was 0.67%, leading to a total return of -6.52%. For the 1-year period, the price return was -7.74%, the dividend return was 0.95%, culminating in a total return of -6.79%. Over the 2-year period, the price return was 17.4%, the dividend return was 2.09%, resulting in a total return of 19.49%. In the 3-year period, the price return was 53.22%, the dividend return was 4.52%, leading to a total return of 57.74%. For the 4-year period, the price return was 94.64%, the dividend return was 6.50%, culminating in a total ret...

Read full news article

Sun Pharmaceutical Sees Heavy Put Option Activity Amid Bearish Sentiment

2026-02-01 11:00:13

Sun Pharmaceutical Industries Ltd has emerged as the most active stock in put options trading, signalling a notable shift in market sentiment. With significant volumes concentrated at the ₹1600 strike price for the 24 February 2026 expiry, investors appear to be positioning for downside risk or hedging against potential volatility in the pharmaceutical giant’s shares.

Read full news article

Sun Pharmaceutical Industries Ltd: Navigating Nifty 50 Membership Amid Mixed Performance

2026-02-01 09:21:08

Significance of Nifty 50 Membership

Being part of the Nifty 50 index confers considerable advantages to Sun Pharmaceutical Industries Ltd, including enhanced visibility among domestic and international investors, increased liquidity, and inclusion in numerous passive investment funds and ETFs. This status often acts as a stabilising factor during volatile market phases, as index funds are mandated to maintain holdings in constituent stocks. However, it also subjects the company to heightened scrutiny and performance expectations relative to peers.

Sun Pharma’s current market capitalisation stands at a robust ₹3,82,694 crores, categorising it firmly as a large-cap stock. This scale underpins its eligibility for index inclus...

Read full news article

Are Sun Pharmaceutical Industries Ltd latest results good or bad?

2026-01-31 19:27:59

Sun Pharmaceutical Industries Ltd's latest financial results for the quarter ending December 2025 highlight a strong operational performance, showcasing the company's ability to maintain momentum across key metrics. The net sales reached ₹15,520.54 crores, reflecting a sequential growth of 7.20% from the previous quarter and a year-on-year increase of 13.49%. This marks the highest quarterly revenue in the company's history, driven by robust demand in both domestic and international markets. The net profit for the same quarter stood at ₹3,368.81 crores, which is an 8.05% increase compared to the previous quarter and a notable 16.03% rise year-on-year. The operating margin for the quarter was reported at 31.99%, showing a sequential improvement of 56 basis points from the prior quarter, indicating enhanced operational efficiency and effective cost management. Additionally, the company's average return on e...

Read full news article

View All News